Optimization of Infliximab Withdrawal Strategy for Rheumatoid Arthritis
NCT02770794
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
211
Enrollment
OTHER
Sponsor class
Conditions
Arthritis, Rheumatoid
Interventions
DRUG:
Infliximab
Sponsor
Chiba University